This inventor holds 2 USPTO granted patents. Top assignee: Eisai Company, Limited. Active years: 1979-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979-1984
Title: The Innovative Contributions of Tsunehiko Kataoka
Introduction: Tsunehiko Kataoka, based in Kakamigahara, Japan, is an inventive force in the field of biotechnology and pharmaceuticals. His remarkable contributions are underscored by his two patents, which showcase his dedication to advancing medical science and health solutions.
Latest Patents: Tsunehiko Kataoka's latest work includes two significant patents. The first is titled "Process for Purifying Elastase," which details a method for purifying elastase by adjusting the electroconductivity of an elastase-containing solution to 3 millimhos per centimeter or less and modifying the pH to a range of 2 to 5. This innovative process allows for the effective precipitation of elastase from an aqueous solution, with ultrafiltration being a preferred technique for adjusting the electroconductivity. The second patent, "Process for the Preparation of Gastrointestinal Hormone," reveals a method through which gastrointestinal hormone is synthesized by heating the small intestine of a mammal in an aqueous salt solution, followed by extraction and purification of the hormone.
Career Highlights: Tsunehiko Kataoka is a professional at Eisai Company, Limited, where he applies his expertise to the development of therapeutic solutions. His innovative approaches and methodologies have made a significant impact within the organization and the wider scientific community.
Collaborations: Throughout his career, Tsunehiko has teamed up with notable colleagues such as Koichi Ogawa and Sinzou Watanabe. Their collaborative efforts reflect a shared commitment to research and innovation in the biotechnology sector.
Conclusion: Tsunehiko Kataoka stands out as a noteworthy inventor whose work significantly contributes to the fields of biotechnology and pharmaceuticals. His patents not only illustrate his technical expertise but also his commitment to improving health outcomes through innovative processes. As he continues his work at Eisai Company, Limited, the scientific community eagerly anticipates his future contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile